Medication: Past, Present, and Future in Racing and Performance Horses - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

Medication: Past, Present, and Future in Racing and Performance Horses

Description:

Medication: Past, Present, and Future in Racing and Performance Horses. Scot Waterman, DVM ... Racing Medication & Testing Consortium ... – PowerPoint PPT presentation

Number of Views:271
Avg rating:3.0/5.0
Slides: 15
Provided by: cynthiakol
Category:

less

Transcript and Presenter's Notes

Title: Medication: Past, Present, and Future in Racing and Performance Horses


1
Medication Past, Present, and Future in Racing
and Performance Horses
  • Scot Waterman, DVM
  • Executive Director

2
Racing Medication Testing Consortium
  • Began in 2001 at a facilitated meeting hosted by
    the AAEP to assess whether uniform medication
    rules were achievable
  • RMTC Goals uniform rules, standardized testing,
    available money for research, improved security,
    information resource for racing commissions
  • Incorporated as a 501 c (3)

3
Board of Directors
  • AAEP
  • AQHA
  • Arabian Jockey Club
  • California TB Trainers
  • Churchill Downs
  • Del Mar
  • Hambletonian Society
  • Harness Tracks of America
  • The Jockey Club     
  • Jockeys Guild
  • Keeneland
  • KTA
  • Magna Entertainment
  • National HBPA
  • NTRA
  • NYRA
  • Oak Tree
  • RCI
  • THA
  • TOBA
  • TB Owners of California
  • TRA
  • TRPB
  • USTA

4
Racing Medication Testing Consortium
  • Diverse, large Board can be difficult but it
    ensures that no single agenda can drive the
    development of a rule, supermajority required for
    language to pass
  • Standard approach is to divide work up into
    sub-committees and bring the consensus back to
    the full Board
  • Language is either adopted by the Board, edited
    and then approved or sent back to the
    sub-committee

5
Veterinarian involvement in the RMTC
  • Board members
  • Rick Arthur
  • (Oak Tree)
  • Nancy Goodman (AQHA)
  • Ted Hill
  • (The Jockey Club)
  • Bobby Lewis
  • (AAEP)
  • Gregg Scoggins
  • (MEC)
  • Ex officio
  • Glenn Blodgett (AQHA)
  • Ron Jensen (Advisor)
  • Milton McLure (AAEP)
  • Wayne McIlwraith (AAEP)
  • Committees
  • Tom Brokken
  • Gary Norwood
  • Dan Wilson
  • Tom Tobin
  • Mike Weber

6
Model Rules Phase 1 (2005)
  • Prohibited Practices
  • Drug Classifications/Categorization
  • Permitted Therapeutics
  • Voluntary use of furosemide with post-race
    regulatory control
  • One of three NSAIDs Bute, Banamine or
    Ketoprofen at 24 hours
  • Adopted now by 32/38 racing jurisdictions

7
Uniform Penalties (2006)
  • Three-tiered grid system simplified existing RCI
    penalties
  • Significantly increases penalties for illegal and
    prohibited performance-enhancing drugs
  • Reduces penalties for therapeutic medication
    mistakes
  • Redefines trainer responsibility
  • Mitigating and aggravating circumstances
    checklist for stewards
  • Added penalties for other culpable licensees
    veterinarians, owners and grooms
  • Adopted as rule or policy in 25 states

8
Model Rules Phase 3 (2007)
  • Regulation of anabolic steroids
  • Thresholds for four FDA-permitted or endogenous
    anabolics
  • Stanozolol
  • Boldenone
  • Nandrolone
  • Testosterone
  • 30-45 days withdrawal time
  • Out-of-competition testing
  • Blood-doping agents EPO Darbypoietin
  • Illegal prohibited drugs

9
Model Rules-Present FutureWithdrawal Times
Research
  • Identify drugs with legitimate uses
  • Prioritize drugs into five groups
  • Collect previous science on each drug
  • If science is insufficient then perform
    administrations on a minimum of 20 horses
  • Plasma is preferred but some drugs will have both
    urine and plasma collected
  • Ultimate goaluniform withdrawal time with a
    corresponding concentration of drug which
    regulates the withdrawal time

10
Withdrawal Times Research
  • Priority Group 1
  • Acepromazine
  • Butorphanol
  • Detomidine
  • Glycopyrrolate
  • Lidocaine
  • Mepivacaine
  • Methocarbamol
  • Pyrilamine
  • Priority Group 2
  • Boldenone
  • Dantrolene
  • Dexamethasone
  • Firocoxib
  • Fluphenazine
  • Hydroxyzine
  • Nandrolone
  • Stanozolol
  • Testosterone

11
Withdrawal Times Research
  • Priority Group 3
  • Albuterol
  • Betamethasone
  • Diclofenac
  • Methylprednisolone
  • Reserpine
  • Triamcinolone
  • Trichlormethiazide
  • Xylazine
  • Priority Group 4
  • Atropine
  • Beclomethasone
  • Buscopan
  • Cromolyn
  • Isoxsuprine
  • Pentoxyfylline
  • Phenytoin
  • Prednisolone

12
Model Rules-Present Future Withdrawal Time
Database
  • Withdrawal times posted for 18 jurisdictions and
    over 70 drugs
  • Database is searchable by drug and by
    jurisdiction
  • Over 2,000 unique users in first month of
    availability
  • www.rmtcnet.com, click on Withdrawal Times tab
    at top of page

13
RMTC-Present FutureDrug Testing Initiatives
  • Develop strategies to improve drug testing in US
  • Integrate WADA laboratory standards
  • Overhaul of Laboratory Quality Assurance Programs
  • Development of a post-doctoral recruitment
    program
  • Development of a business plan for U.S. drug
    testing infrastructure which includes research
    and development laboratory

14
Big picturethe future
  • Beginning to see organizations with sticks use
    them to drive change
  • Thoroughbred Owners and Breeders Association
    Graded Stakes Committee
  • Breeders Cup
  • NTRA Safety Alliance
  • The Jockey Club Safety Committee
  • Hambletonian Society
Write a Comment
User Comments (0)
About PowerShow.com